IndexMethodologyInsightsFor CliniciansRequest Review
⚠️
This device has not received regulatory clearance
This listing is based on publicly available information and has not been verified by the manufacturer or any regulatory authority.
Index/Pipeline/Level 42 AI, Inc.
ALT-006158Pre-approval

imPulse™ Tor System

Level 42 AI, Inc. · Sponsor


Regulatory Pipeline
Proof of Concept
Development
3
Clinical Trial
4
Pre-submission
5
Submitted
6
Under Review
7
Cleared
All identifiers (2)
Aletia (canonical)ALT-006158
ClinicalTrials.gov (primary)NCT05386654
Trial signal only — manufacturer hasn't claimed this listing yet.
The trial data below was imported from ClinicalTrials.gov. If you represent Level 42 AI, Inc., you can claim this listing to add funding, team, and contact details.
Claim this listing →

Clinical Trial Signal

AI/ML Algorithm Training and Validation for the imPulse™ Tor System Self-Directed Systolic & Diastolic Blood Pressure Monitor.
Phase: na15 enrolledUS

Investor Interest

Signal to the team that this device is on your radar. Anonymous — the manufacturer sees the count, not your identity.

0
investors
← Back to Index